DNA Script

Overview

DNA Script, founded in 2014 and based in France, operates within the manufacturing sector, specifically focusing on test and measurement equipment, as well as corporate services in biotechnology and pharmaceuticals. The company specializes in enzymatic DNA synthesis (EDS), which presents a novel approach to producing high-quality DNA oligonucleotides. Traditional methods, primarily based on phosphoramidite solid-phase synthesis, have faced challenges related to accessibility, cost, and environmental sustainability. DNA Script's EDS technology aims to address these issues by enabling rapid, on-demand production of oligos in standard laboratory environments. This process allows for consistent delivery times and customization of sequences, significantly improving the efficiency of oligonucleotide synthesis. Their SYNTAX platform further enhances operational capabilities by generating detailed run reports that include oligo sequences and concentrations. The company's focus on advancing DNA synthesis technology positions it as a notable player in the biotech and pharmaceutical manufacturing landscape.

Industry